Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?

被引：2
|
作者：
Bertoli, Sarah [1 ]
Gadaud, Noemie [2 ]
Tavitian, Suzanne [1 ]
Sarry, Audrey [1 ]
Berard, Emilie [3 ,4 ]
Huguet, Francoise [1 ]
Recher, Christian [1 ,5 ]
机构：
[1] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[2] Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[3] CHU Toulouse, Serv Epidemiol, Toulouse, France
[4] Univ Toulouse 3, INSERM, UMR 1027, Toulouse, France
[5] CNRS, ERL5294, INSERM, UMR1037,Ctr Rech Cancerol Toulouse, Toulouse, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3991.3991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3991
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
    Stone, RM
    Berg, DT
    George, SL
    Dodge, RK
    Paciucci, PA
    Schulman, PP
    Lee, EJ
    Moore, JO
    Powell, BL
    Baer, MR
    Bloomfield, CD
    Schiffer, CA
    BLOOD, 2001, 98 (03) : 548 - 553
  • [32] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [33] Safety and feasibility of outpatient high-dose cytarabine (HIDAC) and intermediate-dose cytarabine (IDAC) for consolidation therapy in acute myeloid leukemia (AML).
    Li, Wenhui
    Simondsen, Katherine
    Lee, Jamie
    Elharake, Maher
    Kubal, Timothy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Shahswar, Rabia
    Beutel, Gernot
    Gabdoulline, Razif
    Schwarzer, Adrian
    Kloos, Arnold
    Koenecke, Christian
    Stadler, Michael
    Gohring, Gudrun
    Behrens, Yvonne Lisa
    Li, Zhixiong
    Dallmann, Louisa-Kristin
    Klement, Piroska
    Albert, Catherin
    Wichmann, Martin
    Alwie, Yasmine
    Benner, Axel
    Saadati, Maral
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    HAEMATOLOGICA, 2024, 109 (01) : 72 - 83
  • [35] EXPERIENCE WITH INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    WILLEMZE, R
    FIBBE, WE
    ZWAAN, FE
    NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (08): : 215 - 219
  • [36] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    Brian McLaughlin
    Annie Im
    Anastasios Raptis
    Mounzer Agha
    Jing-Zhou Hou
    Robert Redner
    Shrina Duggal
    Yan Lin
    Clay Smith
    Michael Boyiadzis
    International Journal of Hematology, 2012, 96 : 743 - 747
  • [37] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    McLaughlin, Brian
    Im, Annie
    Raptis, Anastasios
    Agha, Mounzer
    Hou, Jing-Zhou
    Redner, Robert
    Duggal, Shrina
    Lin, Yan
    Smith, Clay
    Boyiadzis, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (06) : 743 - 747
  • [38] Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine plus cytarabine
    Knoebel, Randall W.
    McQuary, Amy
    Becker, Pamela
    Hendrie, Paul
    Petersdorf, Stephen
    Appelbaum, Frederick R.
    Estey, Eli
    LEUKEMIA RESEARCH, 2011, 35 (09) : E164 - E166
  • [39] Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine -: A pharmacologically based regimen
    Sternberg, DW
    Aird, W
    Neuberg, D
    Thompson, L
    MacNeill, K
    Amrein, P
    Shulman, LN
    CANCER, 2000, 88 (09) : 2037 - 2041
  • [40] AS1411 IN COMBINATION WITH CYTARABINE IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA
    Stuart, K.
    Stockerl-Goldstein, K.
    Cooper, M.
    Devetten, M.
    Herzig, R.
    Medeiros, B.
    Schiller, G.
    Wei, A.
    Acton, G.
    Rizzieri, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 336 - 336
12345